全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Frequency of Hepatic Steatosis among Patients with Hepatitis B Virus Infection at the Borgou-Alibori University Hospital, Benin, in 2025

DOI: 10.4236/ojgas.2026.169038, PP. 394-403

Keywords: Hepatic Steatosis, Hepatitis B Virus, Frequency, Northern Benin

Full-Text   Cite this paper   Add to My Lib

Abstract:

Introduction: Hepatic steatosis is common among patients with hepatitis C virus infection. However, this comorbidity has not been adequately investigated in patients with hepatitis B virus (HBV) infection. The aim of this study was to determine the frequency of hepatic steatosis among patients with HBV infection in northern Benin in 2025. Methods: A cross-sectional study with prospective data collection was conducted between 7 May and 31 August 2025 at the Borgou-Alibori University Hospital (CHUD-B/A). Eligible participants were adults aged ≥ 18 years with chronic HBV infection who attended the Hepatology and Gastroenterology outpatient clinic and had completed the minimum required diagnostic work-up. The dependent variable was the presence of hepatic steatosis as diagnosed by abdominal ultrasonography. Results: Ninety-five patients were included, of whom 13 had hepatic steatosis, yielding a frequency of 13.7%. Their mean age was 43.8 ± 11.5 years. Nine patients (69.2%) were male, corresponding to a male-to-female ratio of 2.2. Eight patients (61.5%) resided in rural areas, and 10 (76.9%) did not engage in regular physical activity. Four patients (30.8%) were overweight, whereas seven (53.8%) were obese. Central obesity was present in 10 patients (76.9%). Conclusion: Hepatic steatosis is common among patients with HBV infection managed at the CHUD-B/A in northern Benin in 2025. A larger-scale study including a greater number of patients is warranted to clarify the relationship between HBV infection and hepatic steatosis and to identify factors independently associated with hepatic steatosis in this population.

References

[1]  Organisation mondiale de la Santé (OMS) (2026) Global Hepatitis Report 2024. Publié à l’occasion du Sommet mondial sur l’hépatite.
https://www.who.int/teams/global-hiv-hepatitis-and-stis-programmes/hepatitis/reports/global-hepatitis-report-2026
[2]  Observatoire africain intégré de la santé (iAHO) and Organisation mondiale de la Santé (OMS) Région africaine (2023) L’élimination de l’hépatite ne peut pas attendre.
https://files.aho.afro.who.int/afahobckpcontainer/production/files/iAHO_Hepatitis_Regional_Factsheet_FR.pdf
[3]  Hatrydt, G.D.K., Gogan, P., Yao-Bathaix, F.M., Mahassadi, A.K. and Koffi, A.A. (2024) Dépistage de la stéatose hépatique par le Fibroscan/CAP chez les sujets noirs africains porteurs d’une Hépatite Virale B chronique en C?te d’Ivoire. Annales Africaines de Medecine, 17, e5495-e5504.
https://doi.org/10.4314/aamed.v17i1.7
[4]  Moro?an, E., Mihailovici, M.S., Giu?c?, S.E., Cojocaru, E., Av?d?nei, E.R., C?runtu, I.D., et al. (2014) Hepatic Steatosis Background in Chronic Hepatitis B and C—Significance of Similarities and Differences. Romanian Journal of Morphology and Embryology, 55, 1041-1047.
[5]  Trabelsi, A.B.S., Ksiaa, M., Souguir, A., Issaoui, A., Sriha, B. and Ajmi, S. (2013) La stéatose hépatique au cours de l’hépatite chronique B: Prévalence, facteurs de risque, et effet sur la fibrose et la réponse thérapeutique. La Tunisie Médicale, 91, 431-434.
[6]  Huang, S. and Liu, C. (2023) Chronic Hepatitis B with Concurrent Metabolic Dysfunction-Associated Fatty Liver Disease: Challenges and Perspectives. Clinical and Molecular Hepatology, 29, 320-331.
https://doi.org/10.3350/cmh.2022.0422
[7]  Djagadou, K.A., Djalogue, L., Klouvi, K. and Djibril, M.A. (2024) Hepatic Steatosis in the Internal Medicine and Medical Emergency Department of the Sylvanus Olympio University Hospital Center. Open Journal of Gastroenterology, 14, 502-511.
https://doi.org/10.4236/ojgas.2024.1412051
[8]  Sokpon, C.N.M., Kpossou, A.R., Sehonou, J., Vignon, R.K., Ahouada, C., Wanvoégbè, F.A., et al. (2019) Stéatose hépatique échographique chez les patients suivis pour hépatite B et/ou C à Cotonou: Prévalence et facteurs associés. Journal de la Société de Biologie Clinique du Bénin, 31, 56-60.
[9]  Saké, K., Attinsounon, C.A., Tchouya Djofang, K.P., Aidéwou, D., Agbessi, N. and Koudoukpo, C. (2017) Séroprévalence des infections par les virus des hépatites B, C et de immunodéficience humaine chez les nouveaux donneurs de sang à Parakou en 2017. Les Cahiers du Centre Béninois de la Recherche Scientifique et de l’Innovation, 19, 150-158.
[10]  Kpossou, A.R., Paraiso, M.N., Sokpon, C.N., Alassan, K.S., Vignon, R.K., Keke, R.K., et al. (2020) Hépatite virale B lors d’une campagne de dépistage en population générale au Bénin: Séroprévalence et facteurs associés. Pan African Medical Journal, 37, Article 247.
https://doi.org/10.11604/pamj.2020.37.247.26070
[11]  Kallel, R., Soumaya, M., Akkari, I., Imen, J. and Ben Jazia, E. (2019) Prévalence et facteurs prédictifs de la stéatose au cours de l’hépatite B chronique et son impact sur la réponse thérapeutique. La Revue de Médecine Interne, 40, A127.
https://doi.org/10.1016/j.revmed.2019.03.144
[12]  Sun, J., Li, Y., Sun, X., Liu, Y., Zheng, D. and Fan, L. (2019) Association between Abdominal Obesity and Liver Steatosis and Fibrosis among Patients with Chronic Hepatitis B Measured by Fibroscan. Experimental and Therapeutic Medicine, 18, 1891-1898.
https://doi.org/10.3892/etm.2019.7727

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133